World Nutraceutical Conference and Expo

Biography

Dr. Weiguo Dai is currently a Scientific Director in Drug Product Development at Johnson and Johnson Pharmaceuticals. He is also one of 62 individuals elected Inaugural JANSSEN FELLOWs, the highly prestigious scientific honor awarded to internationally recognized top scientists within Johnson and Johnson Pharmaceutical R&D for their significant scientific contributions and organizational impacts. Dai is also the recipient of several highly prestigious awards including Johnson and Johnson 2011 Philip B. Hofmann Research Scientist Award in recognition of his “Outstanding Achievement in the Field of Research and Development”. Dr. Dai’s research and innovation have focused on developing patient-centric drug products and improving drug efficacy, safety and patient compliance through design and development of novel formulations, and proprietary delivery technologies and processes. His technology innovations have directly led to the launch of commercial drug products in the market, and established the development projects. Dr. Dai has authored 46 peer-reviewed journal articles, and has been a frequently invited speaker and chair for numerous international conferences and workshops. Also Dr. Dai currently serves as Vice Chair of Physical Pharmacy and Biopharmaceutics (PPB) section in AAPS. Additionally, he is the current President of Sino-American Pharmaceutical Professionals Association (SAPA)-Greater Philadelphia. SAPA is a nonprofit and pharmaceutical professional organization with over 4,000 members. Dr. Dai earned his PhD degree from The Johns Hopkins University in 1996, and has over 17 years of industrial work experience in biotech/pharmaceutical companies, including Guilford (now Eisai), Amgen, and Johnson and Johnson.

Research Interest

Health and Wellness